Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics
about
Identification of HEXIM1 as a positive regulator of p53Inhibition of human immunodeficiency virus type-1 by cdk inhibitorsTargeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs.CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90.Role of cellular iron and oxygen in the regulation of HIV-1 infection.Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue.Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction.Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replicationAnalysis of the roles of HIV-derived microRNAs.6-desfluoroquinolones as HIV-1 Tat-mediated transcription inhibitors.The cyclin-dependent kinase family in the social amoebozoan Dictyostelium discoideum.Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.Curcumin and its analogues: a potential natural compound against HIV infection and AIDS.Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV.Synthesis, structure-activity relationship studies and biological evaluation of novel 2,5-disubstituted indole derivatives as anticancer agents.Potential Use of Flavopiridol in Treatment of Chronic Diseases.Computer-aided design, synthesis and validation of 2-phenylquinazolinone fragments as CDK9 inhibitors with anti-HIV-1 Tat-mediated transcription activity.HIV-1 infection suppresses expression of host cell cycle-associated gene PDS5A.Structural Bioinformatics Approach of Cyclin-Dependent Kinases 1 and 3 Complexed with Inhibitors.CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.Short communication: adhesion pathways utilized by HIV-infected lymphocytes.The cyclin-dependent kinase inhibitor roscovitine inhibits kinase activity, cell proliferation, multicellular development, and Cdk5 nuclear translocation in Dictyostelium discoideum.
P2860
Q24297975-8AA6696D-D6FD-47CC-9764-AD3D252C008AQ33780297-766EFBF9-DD06-40CE-ADF6-3F3959F1ED1AQ33793543-0B76AA10-29C0-486E-B35B-990E3401DDDAQ34830422-5C38A7CF-EC53-45BF-900F-ACAD3E33A271Q36448119-0C61254B-9392-4BA5-AFD9-5EA8D096F191Q36839068-025911AB-C42A-4C8A-966D-E065E9552855Q37098618-60DEE9F4-779B-4AAD-929A-A4A40C043BC9Q37354387-9B01DA1E-A57B-40CD-BD69-61AC34FAE186Q37368099-F583D1D6-6920-4D0A-B87C-77DD804BA991Q37816443-1669D419-54A8-4794-ABFD-179199E93774Q37855902-A798E9D3-BF69-42BC-B398-55133F329BA5Q38131284-3A228156-AC71-4C5C-9359-56BE1183C556Q38212101-140AE22A-04DA-445F-A114-CE2605ED32E2Q38592538-3CC3E9FF-1B07-4D9E-BBDD-459832491BA5Q38757713-7103C4C7-94D1-4255-89E2-F84D89928C23Q38763764-721355A0-73F8-44F2-B251-F7BD7D201849Q38988581-372F6476-F1DB-4960-AAC8-FCE6F9965ABDQ39073158-967845E4-C0C4-4D04-8DDF-B83498CA85E6Q39484912-A76A4BC5-D368-4445-B65A-39548DC424FBQ39551472-60D028C1-6EDC-468D-A9FC-A931B63F2E7CQ39764495-ACAA0DAB-FF95-4E12-877B-05E5BF08BFA7Q42348446-D5691D0B-E0EB-4BC5-8CC7-BCC97D1EDEF7Q54537089-BA6815B5-4955-4AB9-B893-B9595781A491
P2860
Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@ast
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@en
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@nl
type
label
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@ast
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@en
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@nl
prefLabel
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@ast
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@en
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@nl
P2093
P1476
Potential use of pharmacologic ...... itors as anti-HIV therapeutics
@en
P2093
Anne Pumfery
Cynthia de la Fuente
Fatah Kashanchi
Reem Berro
Sergei Nekhai
Sheng-Hao Chao
P304
P356
10.2174/138161206777442083
P407
P577
2006-01-01T00:00:00Z